Tradition meets Tech: UMMS Students Explore Medicine in China

Medical students spent two weeks in China as part of a unique program that combined clinical and cultural exchange.

Author | Craig McCool

UMMS students in Guangzhou
The UMMS delegation in Guangzhou as part of the US-China Health Dialogue Program.

Six UMMS students recently traveled to China as part of the U.S.-China Youth Health Dialogue Program, an exchange designed to build bridges between future medical leaders in both nations.

Joining peers from other U.S. institutions as well as counterparts from China, the participants visited multiple hospitals and healthcare centers in three cities—Guangzhou, Fuzhou, and Beijing—touring facilities, observing patient care, and engaging with providers across numerous specialties.

“These experiences broaden our understanding of medicine and the diverse ways it can be delivered and perceived by patients,” said third-year student Max Wagner. “We embraced so many opportunities to step outside our U.S.-based clinical lens to see patient care from a new cultural perspective.”

Wagner and other participants gained firsthand exposure to China’s East-meets-West approach to healthcare, from learning how artificial intelligence is being used to integrate VR and 3D organ modeling in the operating room, to watching traditional techniques such as cupping and acupuncture in practice.

“It made me reflect on how similar programs could be implemented at our own institution to help students get involved in community service during clinical training,” said Marina Khreizat, also an M3. “As a future physician, I want to remain open-minded to the beliefs and practices that shape how patients view their health and treatment.”

This marked the second year that UMMS students have participated in the Health Dialogue, which also included students from the University of California and the University of Chicago.

Global REACH collaborated with the UMMS Office of Medical Student Education to select participants and coordinate aspects of the experience, including a visit to Peking Union Medical College Hospital, a longtime institutional partner.

“Programs like this offer far more than clinical insight—they challenge our students to think beyond borders, engage with diverse systems of care, and appreciate the cultural contexts that shape health outcomes,” said Amy Huang, MD, Director of Asia Programs at Global REACH. “Such experiences are essential in preparing the next generation of physicians to lead with empathy, adaptability, and a truly global perspective.”

Featured News & Stories

screenshot of the taping of the podcast episode, showing 5 speakers on zoom
Department News

Youth Suicide Prevention Initiative at the forefront of vital mental health care

Youth Suicide Prevention Initiative at the forefront of vital mental health care
people crowd aerial network connections
Health Lab

New insight into how lipodystrophy can affect overall health

What is lipodystrophy? Expert insights on partial vs. generalized fat loss, health complications, leptin therapy, and emerging clinical research.
little boy at table smiling in library
Health Lab

Nerf gun accident causes retinal detachment in pediatric patient

An 8-year-old boy suffered a retinal detachment after a Nerf dart injury, requiring surgery at University of Michigan Health’s Kellogg Eye Center. Learn the warning signs of toy gun eye injuries and why protective eyewear is essential for children.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

PMOS is the New PCOS

What the shift from PCOS to PMOS means for your fertility journey.
Department News

Gray Areas: Realistic Possibility of Reversing Diabetic Neuropathy

Brian Callaghan, MD, MS, professor of neurology at the University of Michigan, discusses the clinical debate around whether diabetic peripheral neuropathy is reversible if diagnosed and treated early enough.
red blood cells going through clear tube red background
Health Lab

FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.